Advanced search
Publication Cover
Gynecological Endocrinology Volume 26, 2010 - Issue 8
Submit an article Journal homepage
88
Views
6
CrossRef citations to date
0
Altmetric
BONE

The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins

Marek BolanowskiDepartment of Endocrinology, Diabetology and Isotope Therapy, Medical University, Wroclaw, PolandCorrespondence[email protected]
,
Beata Zadrożna-ŚliwkaDepartment of Endocrinology, Diabetology and Isotope Therapy, Medical University, Wroclaw, Poland
,
Aleksandra JawiarczykDepartment of Endocrinology, Diabetology and Isotope Therapy, Medical University, Wroclaw, Poland
&
Joanna SyryckaDepartment of Endocrinology, Diabetology and Isotope Therapy, Medical University, Wroclaw, Poland
Pages 623-627 | Received 09 Sep 2009, Accepted 20 Jan 2010, Published online: 10 Mar 2010

References

  • Akdeniz N, Akpolat V, Kale A, Erdemoglu M, Kuyumcuoglu U, Celik Y. Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset. Gynecol Endocrinol 2009;25:125–129.
  • Lorenc RS, Misiorowski W, Karczmarewicz E. Critical points in strategies for the diagnosis and treatment of osteoporosis. Endokrynol Pol 2009;60:124–133.
  • Vartej P, Poiana C, Vartej I. Effects of hyperprolactinaemia on osteoporotic fracture risk in premenopausal women. Gynecol Endocrinol 2001;15:43–47.
  • Vestergaard P, Jorgensen JOL, Hagen C, Hoeck HC, Lauberg P, Rejnmark L, Brixen K, Weeke J, Andersen M, Conceicao FL, et al Fracture risk increased in patients with GH deficiency or untreated prolactinomas – a case–control study. Clin Endocrinol 2002;56:159–167.
  • Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002;77:453–468.
  • Zadrożna-Śliwka B, Bolanowski M, Jawiarczyk A, Kałużny M, Syrycka J. The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin. Neuro Endocrinol Lett 2008;29:178–184.
  • Mah PM, Webster J. Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med 2002;20:365–374.
  • Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med 1999;44:1085–1090.
  • Zadrożna-Śliwka B, Bolanowski M, Kałużny M, Syrycka J. Bone mineral density and bone turnover in hyperprolactinemia of various origins. Endokrynol Pol 2007;58:116–122.
  • Aron DC, Findling JW, Tyrrell JB. Hypothalamus and pituitary gland. In: Greenspan FS, Gardner DG, editors. Basic and clinical endocrinology. 7th ed. Lange Medical Books/McGraw-Hill; 2004. pp 106–175.
  • Balasch J. Sex steroids and bone: current perspectives. Hum Reprod Update 2003;9:207–222.
  • Wardlow SL, Bilezikian JP. Hyperprolactinemia and osteopenia [Editorial]. J Clin Endocrinol Metab 1992;75:690–691.
  • Biller BMK, Baum HBA, Rosenthal DI, Saxe VC, Charpie PM, Klibanski A. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 1992;75:692–697.
  • Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 1988;67:124–130.
  • Schlechte J, Walkner L, Kathol M. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. J Clin Endocrinol Metab 1992;75:698–703.
  • Lewiecki EM, Kendler DL, Kiebzak GM, Schmeer P, Prince RL, El-Hajj Fuleihan G, Hans D. Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 2004;15:779–784.
  • Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, Philips DL, Rogers TN, Clark RV. Sex steroids and bone density in premenopausal women. J Clin Endocrinol Metab 1989;69:533–539.
  • Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin Endocrinol 2000;52:319–327.
  • Fiore CE, D'Agata R, Clementi G, Malatino LS. Prolactin and calcium metabolism: influence of hyperprolactinaemia on immunoreactive parathyroid hormone levels in man and in the rat. J Endocrinol Invest 1984;7:647–652.
  • Franek E, Piwowarska I, Bułanowski M, Kokot F, Więcek A. Serum concentration of 1-84 (cyclase-activating) and 7-84 (cyclase-inhibiting) parathormone in elderly women with low mineral density of the trabecular bone. Endokrynol Pol 2008;59:471–476.
  • Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 2001;60:1460–1468.
  • Kameda T, Mano H, Yuasa T, Mori Y, Miyzawa K, Shiokawa M, Nakamuru Y, Hiroi E, Hiura K, Kameda A, et al Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 1997;186:489–495.
  • Koppelman MC, Kurtz DW, Morrish KA, Bou E, Susser JK, Shapiro JR, Loriaux DL. Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab 1984;59:1050–1053.
  • Schlechte JA. Clinical impact of hyperprolactinaemia. Baillieres Clin Endocrinol Metab 1995;9:359–366.
  • Schlechte J, el-Khoury G, Kathol M, Walkner L. Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 1987,64:1021–1026.
  • Potts JT. Parathyroid hormone: past and present. J Endocrinol 2005;187:311–325.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.